Eagle Capital Management TEVA-OLD trades
Ravenel Boykin Curry IV
Eagle Capital Management Teva Pharma Industries Ltd ADR stake
total: 177
Trades details
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2013 Q2 or earlier
- Held for:
- 2+ quarters
- Latest activity:
- 2013 Q4
According to 2026 Q2 report, Eagle Capital Management doesn't hold any Teva Pharma Industries Ltd ADR (TEVA-OLD) shares. Eagle Capital Management has held TEVA-OLD since at least 2013 Q2 with 22,400 shares in our earliest available record. Since at least 2013 Q2, Eagle Capital Management has made 1 more transaction.
When did Eagle Capital Management sell Teva Pharma Industries Ltd ADR (TEVA-OLD)?
Eagle Capital Management sold off the entire Teva Pharma Industries Ltd ADR (TEVA-OLD) position in 2013 Q4.
Estimated cost basis*
- Weighted AVG buy price:
- $39.20
- Weighted AVG sell price:
- $37.77
Eagle Capital Management's historical trades in Teva Pharma Industries Ltd ADR
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.